Draft Commission Implementing Decision (EU) not renewing the approval of medetomidine as an active substance for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council; (6 page(s), in English)

Partial amendment to the Minimum Requirements for Biological Products Partial amendment to The Public Notice on National Release Testing.; (1 page(s), in English)

Partial amendment to the Criteria for vascular prosthesis and the Criteria for medical adhesive, and abolishment of the Criteria for vision corrective contact lens; (2 page(s), in English)